methotrexate has been researched along with Stroke in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (9.09) | 29.6817 |
| 2010's | 24 (72.73) | 24.3611 |
| 2020's | 6 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Astorquizaga, L; Cheistwer, A; Font, D; Marin, F; Palmieri, F | 1 |
| Andión-Catalán, M; García-Salido, A; Lassaleta-Atienza, Á; Leoz-Gordillo, I; López-De Suso, D; Sirvent-Cerdá, S | 1 |
| Almeida, JR; Brouwer, ES; Burn, E; Carmona, L; Chatzidionysiou, K; Duarte-Salles, T; Fakhouri, W; Hottgenroth, A; Jani, M; Kolde, R; Kors, JA; Kullamaa, L; Lane, J; Marinier, K; Michel, A; Prats-Uribe, A; Prieto-Alhambra, D; Reisberg, S; Rijnbeek, PR; Ryan, P; Sena, AG; Stewart, HM; Swerdel, JN; Torre, CO; Verhamme, K; Vizcaya, D; Weaver, J; Williams, RD; Yang, C | 1 |
| Schmidt, WA | 1 |
| Kaneko, Y; Takanashi, S; Takeuchi, T | 1 |
| Anderson, DR; Baker, JF; England, BR; George, MD; Johnson, TM; Liao, KP; Mikuls, TR; Roul, P; Sauer, B; Sayles, HR; Zheng, C | 1 |
| Boehm, M; Hallenbeck, J; Hollander, MC; Ishii, H; Latour, LL; Lin, PC; Merchant, AS; Min, Y; Munasinghe, J; Ray-Choudhury, A; Xiao, Z; Yang, D; Yang, L | 1 |
| Akbaraly, T; Deneux, V; Haouy, S; Leboucq, N; Saumet, L; Sirvent, N | 1 |
| Kanfi, A; Samanta, D; Willis, E | 1 |
| Chen, CH; Chen, CM; Chiou, JY; Leong, PY; Li, YC; Lin, LC; Tam, HW; Wang, YH; Wei, JC | 1 |
| Ago, T; Kitayama, J; Kitazono, T; Okata, T; Sambongi, Y; Tanimoto, K; Yamanaka, I; Yamanaka, K | 1 |
| Arakawa, Y; Hanada, R; Ikeda, Y; Isobe, K; Koh, K; Mori, M; Oguma, E; Oyama, C; Sasaki, K; Uehara, T; Watanabe, K; Yanagi, M | 1 |
| Bertrand, O; Butman, S; Clearfield, M; Everett, BM; Glynn, RJ; Goldhaber, SZ; Gupta, M; Hasan, A; Iturriaga, E; Johnston, J; Le May, M; Libby, P; MacFadyen, JG; Mam, V; Ofori, C; Paynter, NP; Pradhan, A; Ridker, PM; Rosenberg, Y; Saklayen, M; Seagle, R; Singh, N; Solomon, DH; Tsigoulis, M; Verma, S; Zaharris, E | 1 |
| Evers, D; Klijn, CJM; Maas, RPPWM; Pegge, SAH; van Samkar, A | 1 |
| Cossburn, MD; Harris, MJ; Pengas, G | 1 |
| Ridker, PM | 1 |
| Goyal, M; Pandey, A | 1 |
| Chen, L; Curtis, JR; Graham, DJ; Griffin, MR; Harrold, LR; Herrinton, LJ; Kowal, MK; Kuriya, B; Lewis, JD; Lii, J; Liu, L; Rassen, JA; Saag, KG; Solomon, DH | 1 |
| Ahlehoff, O; Bryld, LE; Gislason, G; Gniadecki, R; Hansen, PR; Iversen, L; Kristensen, SL; Lasthein, S; Lindhardsen, J; Skov, L; Torp-Pedersen, C | 1 |
| Baud, JM; Chadenat, ML; Herlin, B; Pico, F | 1 |
| Ambrosetti, A; Balzarotti, M; Binder, M; Cavalli, F; Cwynarski, K; Deckert, M; Fabbri, A; Ferrari, A; Ferreri, AJ; Finke, J; Fox, CP; Gørløv, JS; Hemmaway, C; Hertenstein, B; Hess, G; Illerhaus, G; Johnson, P; Keller, U; Krause, SW; Levis, A; Linton, KM; Panse, J; Pisani, F; Politi, LS; Ponzoni, M; Pukrop, T; Pulczynski, E; Reni, M; Rosée, PL; Roth, A; Rudà, R; Schmoll, HJ; Schorb, E; Stilgenbauer, S; Torri, V; Tucci, A; Zucca, E | 1 |
| Ho, A; Kurtzman, DJ; Rubenstein, MH; Vleugels, RA; Wright, NA | 1 |
| Cloutier, M; Dea, K; Guérin, A; Mulani, P; Sundaram, M; Wu, JJ | 1 |
| Drachtman, RA; Haines, C; Pan, WJ; Rogers, P | 1 |
| Alpern, ER; Thomas, N | 1 |
| El-Hakam, LM; Illner, A; Ramocki, MB; Riviello, JJ | 1 |
| Agarwal, A; Ouyang, T; Thamburaj, K; Vijay, K | 1 |
| Hattori, N; Nishioka, K; Sasaki-Ikesawa, K; Shimura, H; Tanaka, R; Tanaka, S | 1 |
| Daïen, CI; Fesler, P | 1 |
| Bond, J; Goulden, N; Hough, R; Mitchell, C; Moppett, J; Vora, A | 1 |
| Baldini, L; Balzarotti, M; Bernardi, M; Bobbio, F; Brandes, AA; Caligaris Cappio, F; Corazzelli, G; Dell'Oro, S; Ferreri, AJ; Foppoli, M; Ilariucci, F; Montanari, M; Picozzi, P; Ponzoni, M; Reni, M; Spina, M; Stelitano, C; Tosoni, A; Zaja, F | 1 |
| Baehring, JM; Fulbright, RK | 1 |
4 review(s) available for methotrexate and Stroke
| Article | Year |
|---|---|
Methotrexate-induced stroke-like neurotoxicity: Case report, 8 years of experience, and literature review.
Topics: Antimetabolites, Antineoplastic; Humans; Methotrexate; Neurotoxicity Syndromes; Stroke | 2022 |
[Inflammatory Muscle Pain: Polymyalgia Rheumatica with or without Large Vessel Vasculitis].
Topics: Aged; Antibodies, Monoclonal, Humanized; Blindness; Diagnosis, Differential; Fatigue; Female; Giant Cell Arteritis; Humans; Methotrexate; Polymyalgia Rheumatica; Prednisolone; Stroke; Ultrasonography; Vasculitis | 2020 |
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; CD40 Antigens; CD40 Ligand; Diabetes Mellitus, Type 2; Disease Models, Animal; Hematopoiesis; Humans; Inflammasomes; Interleukin-18; Interleukin-1beta; Interleukin-6; Methotrexate; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Signal Transduction; Stroke; Thrombosis; Triggering Receptor Expressed on Myeloid Cells-1 | 2019 |
[Rheumatoid arthritis: a cardiovascular disease?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Humans; Inflammation; Methotrexate; Risk Factors; Stroke; Tumor Necrosis Factor-alpha | 2012 |
3 trial(s) available for methotrexate and Stroke
| Article | Year |
|---|---|
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Topics: Aged; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Confidence Intervals; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Interleukin-1beta; Interleukin-6; Male; Metabolic Syndrome; Methotrexate; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Statistics, Nonparametric; Stroke; Transaminases | 2019 |
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Topics: Acute Kidney Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Comparative Effectiveness Research; Cytarabine; Death, Sudden; Denmark; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Diseases; Germany; Heart Injuries; Hematopoietic Stem Cell Transplantation; Humans; Hyperglycemia; Induction Chemotherapy; Infections; Intraocular Lymphoma; Italy; Kaplan-Meier Estimate; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mucositis; Neurotoxicity Syndromes; Neutropenia; Optic Nerve Neoplasms; Poisoning; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Stroke; Switzerland; Thiotepa; Thrombocytopenia; Thrombosis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; United Kingdom | 2016 |
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Hematologic Diseases; Humans; Idarubicin; Life Tables; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Remission Induction; Stroke; Survival Analysis; Thiotepa | 2006 |
26 other study(ies) available for methotrexate and Stroke
| Article | Year |
|---|---|
[Methotrexate-induced stroke-like syndrome: A pediatric case report].
Topics: Antimetabolites, Antineoplastic; Child; Humans; Methotrexate; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stroke | 2021 |
Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Humans; Methotrexate; Outcome Assessment, Health Care; Stroke | 2022 |
Elderly patients with comorbidities in the definition of difficult-to-treat rheumatoid arthritis.
Topics: Abatacept; Age Factors; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Comorbidity; Drug Resistance; Female; Fractures, Bone; Glucocorticoids; Humans; Hypertension; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Myocardial Ischemia; Prednisolone; Renal Insufficiency, Chronic; Severity of Illness Index; Stroke; Tumor Necrosis Factor Inhibitors | 2021 |
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Coronary Artery Disease; Female; Heart Disease Risk Factors; Heart Failure; Hospitalization; Humans; Incidence; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Stroke | 2021 |
Attenuation of Myeloid-Specific TGFβ Signaling Induces Inflammatory Cerebrovascular Disease and Stroke.
Topics: Animals; Cell Line; Immunosuppressive Agents; Inflammation; Metformin; Methotrexate; Mice; Mice, Inbred C57BL; Myeloid Cells; NF-kappa B; Penetrance; Signal Transduction; Stroke; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2017 |
[Acute methotrexate-related neurotoxicity and pseudo-stroke syndrome].
Topics: Acute Disease; Adolescent; Antimetabolites, Antineoplastic; Child; Diagnosis, Differential; Female; Humans; Leukoencephalopathies; Male; Methotrexate; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stroke; Syndrome | 2017 |
A Not Uncommon Cause of Stroke Mimicker in Children.
Topics: Adolescent; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stroke | 2018 |
Methotrexate might reduce ischemic stroke in patients with rheumatoid arthritis: a population-based retrospective cohort study.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Databases, Factual; Female; Humans; Hydroxychloroquine; Incidence; Male; Methotrexate; Middle Aged; Protective Factors; Retrospective Studies; Risk Factors; Stroke; Sulfasalazine; Taiwan; Treatment Outcome | 2018 |
Subacute Methotrexate Encephalopathy Mimicking Ischemic Stroke With Dynamic Changes on Magnetic Resonance Imaging.
Topics: Adult; Antimetabolites, Antineoplastic; Brain Ischemia; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Dysarthria; Early Diagnosis; Encephalitis; Female; Humans; Lymphoma, B-Cell; Methotrexate; Paresis; Predictive Value of Tests; Stroke | 2018 |
Characteristics of methotrexate-induced stroke-like neurotoxicity.
Topics: Antimetabolites, Antineoplastic; Blood Coagulation; Blood Coagulation Tests; Child; Child, Preschool; Diagnosis, Differential; Female; Hematologic Neoplasms; Humans; Leukoencephalopathies; Male; Methotrexate; Neurotoxicity Syndromes; Retrospective Studies; Stroke | 2018 |
Methotrexate-induced toxic leukoencephalopathy: an uncommon stroke mimic.
Topics: Antimetabolites, Antineoplastic; Brain; Diagnosis, Differential; Female; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Methotrexate; Stroke; Young Adult | 2019 |
Multiple cerebral infarcts: a rare complication of neurosarcoidosis.
Topics: Adrenal Cortex Hormones; Central Nervous System Diseases; Cerebral Infarction; Humans; Hydrocephalus; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Sarcoidosis; Stroke | 2019 |
Methotrexate: CIRTified for preventing atherosclerotic events?
Topics: Antirheumatic Agents; Atherosclerosis; Hospitalization; Humans; Methotrexate; Myocardial Infarction; Stroke | 2019 |
Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Cohort Studies; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Proportional Hazards Models; Retrospective Studies; Risk; Stroke; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.
Topics: Adult; Aged; Anti-Inflammatory Agents; Biological Products; Cardiovascular Diseases; Cause of Death; Climatotherapy; Cyclosporine; Denmark; Dermatologic Agents; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Methotrexate; Middle Aged; Myocardial Infarction; Phototherapy; Psoriasis; Registries; Retinoids; Severity of Illness Index; Stroke; Tumor Necrosis Factor-alpha; Ustekinumab | 2015 |
Contrast-enhanced ultrasonography in Takayasu arteritis: watching and monitoring the arterial inflammation.
Topics: Adrenal Cortex Hormones; Adult; Carotid Artery, Common; Contrast Media; Disease Management; Humans; Male; Methotrexate; Stroke; Takayasu Arteritis; Tissue Plasminogen Activator; Ultrasonography | 2015 |
Unilateral Gottron Papules in a Patient Following a Stroke: Clinical Insights Into the Disease Mechanisms and Pathophysiology of Cutaneous Dermatomyositis.
Topics: Biopsy, Needle; Dermatomyositis; Drug Therapy, Combination; Female; Hand Dermatoses; Humans; Hydroxychloroquine; Immunohistochemistry; Methotrexate; Middle Aged; Stroke; Treatment Outcome | 2016 |
Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-α inhibitors versus methotrexate.
Topics: Adalimumab; Adolescent; Adult; Aged; Angina, Unstable; Cardiovascular Diseases; Dermatologic Agents; Etanercept; Female; Humans; Infliximab; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Protective Factors; Psoriasis; Risk Assessment; Stroke; Time Factors; Tumor Necrosis Factor-alpha; Young Adult | 2017 |
A Stroke Mimic: Methotrexate-induced Neurotoxicity in the Emergency Department.
Topics: Adolescent; Antimetabolites, Antineoplastic; Combined Modality Therapy; Dextromethorphan; Emergency Service, Hospital; Excitatory Amino Acid Antagonists; Facial Paralysis; Female; Humans; Lower Extremity; Methotrexate; Muscle Hypotonia; Muscle Weakness; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stroke; Upper Extremity | 2017 |
A Stroke Mimic: A 14-Year-Old Cancer Patient Presenting With Acute Right-Sided Weakness.
Topics: Adolescent; Antimetabolites, Antineoplastic; Brain; Diagnosis, Differential; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Methotrexate; Paresis; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Stroke | 2017 |
Hyperperfusion on magnetic resonance imaging in acute chemotherapy-related leukoencephalopathy.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Diagnosis, Differential; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Methotrexate; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stroke; Vincristine | 2010 |
Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke.
Topics: Adolescent; Antimetabolites, Antineoplastic; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Humans; Injections, Spinal; Leukoencephalopathies; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stroke | 2011 |
Methotrexate leukoencephalopathy mimics acute progressive stroke.
Topics: Adolescent; Antimetabolites, Antineoplastic; Diagnosis, Differential; Humans; Leukoencephalopathies; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stroke | 2011 |
'Stroke-like syndrome' caused by intrathecal methotrexate in patients treated during the UKALL 2003 trial.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Female; Humans; Injections, Spinal; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stroke; United Kingdom | 2013 |
Heart risks of RA drugs compared. Biologics confer same risk as old-fashioned methotrexate; cytotoxic drugs increase cardiac risk.
Topics: Arthritis, Rheumatoid; Humans; Immunosuppressive Agents; Methotrexate; Myocardial Infarction; Stroke | 2007 |
Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients.
Topics: Adult; Aged; Antineoplastic Agents; Brain; Brain Edema; Capecitabine; Dementia, Vascular; Deoxycytidine; Diffusion Magnetic Resonance Imaging; Energy Metabolism; Female; Fluorouracil; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Infusions, Intravenous; Injections, Spinal; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasms; Nerve Fibers, Myelinated; Neurologic Examination; Registries; Remission, Spontaneous; Stroke; Tegafur | 2008 |